Mirtha Guitelman

1.8k total citations
26 papers, 625 citations indexed

About

Mirtha Guitelman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Mirtha Guitelman has authored 26 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 3 papers in Physiology. Recurrent topics in Mirtha Guitelman's work include Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (19 papers) and Adrenal and Paraganglionic Tumors (12 papers). Mirtha Guitelman is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (19 papers) and Adrenal and Paraganglionic Tumors (12 papers). Mirtha Guitelman collaborates with scholars based in Argentina, United States and Brazil. Mirtha Guitelman's co-authors include Mônica R. Gadelha, Marcello D. Bronstein, Ilan Shimon, Gérald Raverot, Maria Fleseriu, Thierry Brue, Alberto M Pedroncelli, Annamaria Colao, Mounir Aout and Vyacheslav Pronin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and The Lancet Diabetes & Endocrinology.

In The Last Decade

Mirtha Guitelman

22 papers receiving 610 citations

Peers

Mirtha Guitelman

EDM

SURGE

EPIDE

GENET

Ian Sabin United Kingdom

Rob van der Pas Netherlands

Raluca Trifănescu Romania

R. J. W. de Keizer Netherlands

Berna İmge Aydoğan Türkiye

Anne Thiel Germany

Anne Cailleux France

Crystal Kamilaris United States

Corbin P. Roudebush United States

Kari Lima Norway

Ian Sabin United Kingdom

Mirtha Guitelman

531 ×1.0

EDM

340 ×1.3

SURGE

106 ×0.6

EPIDE

82 ×1.1

GENET

28 ×0.5

Citations per year, relative to Mirtha Guitelman Mirtha Guitelman (= 1×) peers Ian Sabin

Countries citing papers authored by Mirtha Guitelman

Since Specialization

Citations

This map shows the geographic impact of Mirtha Guitelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirtha Guitelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirtha Guitelman more than expected).

Fields of papers citing papers by Mirtha Guitelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirtha Guitelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirtha Guitelman. The network helps show where Mirtha Guitelman may publish in the future.

Co-authorship network of co-authors of Mirtha Guitelman

This figure shows the co-authorship network connecting the top 25 collaborators of Mirtha Guitelman. A scholar is included among the top collaborators of Mirtha Guitelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirtha Guitelman. Mirtha Guitelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biller, Beverly M. K., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2025). OR12-07 Disease Control in Patients With Acromegaly Switching From Injected Somatostatin Receptor Ligands to Once-Daily Oral Paltusotine: Interim Results of the PATHFNDR-1 Open-Label Extension. Journal of the Endocrine Society. 9(Supplement_1).

Guitelman, Mirtha, et al.. (2025). New insights in cellular senescence: The pituitary model. Journal of Neuroendocrinology. 37(5). e70008–e70008.

Gadelha, Mônica R., Christian J. Strasburger, Martin Bidlingmaier, et al.. (2024). Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine. The Journal of Clinical Endocrinology & Metabolism. 110(1). 228–237. 12 indexed citations

Pignataro, Omar P., et al.. (2022). Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism. Journal of Feline Medicine and Surgery. 24(12). 1238–1244. 10 indexed citations

Guitelman, Mirtha, et al.. (2020). Non-functioning pituitary adenomas and pregnancy: one-center experience and review of the literature. Archives of Endocrinology and Metabolism. 64(5). 614–622. 2 indexed citations

Guarda, Francisco J., Weiyan Gong, Alireza Ghajar, Mirtha Guitelman, & Lisa B. Nachtigall. (2020). Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature. Pituitary. 23(5). 498–506. 4 indexed citations

Guitelman, Mirtha, et al.. (2020). MON-326 Non Functioning Pituitary Adenomas (NFPA): Sex Related Differences in Presentation, Clinical Features and Outcomes. Journal of the Endocrine Society. 4(Supplement_1).

Fuertes, Mariana, et al.. (2018). New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A. Frontiers in Endocrinology. 9. 262–262. 6 indexed citations

Gadelha, Mônica R., Marcello D. Bronstein, Thierry Brue, et al.. (2014). Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial. The Lancet Diabetes & Endocrinology. 2(11). 875–884. 284 indexed citations

10.

Guitelman, Mirtha, et al.. (2013). Patient-focussed outcomes in acromegaly. Pituitary. 17(S1). 18–23. 5 indexed citations

11.

Guitelman, Mirtha, Michael G. Vitale, Alberto Chervín, et al.. (2012). Primary empty sella (PES): a review of 175 cases. Pituitary. 16(2). 270–274. 1 indexed citations

12.

Mallea-Gil, Susana, et al.. (2012). IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome.. SHILAP Revista de lepidopterología. 42(1). 20–6. 28 indexed citations

13.

Boero, Laura, Marcos Manavela, Karina Danilowicz, et al.. (2011). Comparison of two immunoassays in the determination of IGF-I levels and its correlation with oral glucose tolerance test (OGTT) and with clinical symptoms in acromegalic patients. Pituitary. 15(4). 466–471. 9 indexed citations

14.

Martínez, Maria Paz, et al.. (2010). Endocrine manifestations of Langerhans cell histiocytosis diagnosed in adults. Pituitary. 13(4). 298–303. 30 indexed citations

15.

Barkan, Ariel L., Marcello D. Bronstein, Oscar D. Bruno, et al.. (2009). Management of acromegaly in Latin America: expert panel recommendations. Pituitary. 13(2). 168–175. 24 indexed citations

16.

Guitelman, Mirtha. (2006). Long-Term Follow-Up of Prolactinomas: Should Dopamine Agonist Treatment Be Life-Long?. Frontiers of hormone research. 35. 88–101. 6 indexed citations

17.

Arzt, Eduardo, Marcello D. Bronstein, & Mirtha Guitelman. (2006). Pituitary Today: Molecular, Physiological and Clinical Aspects. Frontiers of hormone research.

18.

Day, Patricia, et al.. (2005). Retrospective Multicentric Study of Pituitary Incidentalomas. Pituitary. 1 indexed citations

19.

Day, Patricia, et al.. (2004). Retrospective Multicentric Study of Pituitary Incidentalomas. Pituitary. 7(3). 145–148. 76 indexed citations

20.

Guitelman, Mirtha, et al.. (2002). Hyperprolactinemia in Asymptomatic Patients is Related to High Molecular Weight Posttranslational Variants or Glycosylated Forms. Pituitary. 5(4). 255–260. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact